Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heartburn”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Large-scale testing (Phase 3)Study completedNCT00321984
What this trial is testing

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 947
Large-scale testing (Phase 3)Study completedNCT00553449
What this trial is testing

Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.

Who this might be right for
Gastroesophageal RefluxHeartburn
Janssen-Ortho Inc., Canada 48
Post-approval studies (Phase 4)Study completedNCT00318084
What this trial is testing

PPI Test in GP Patients

Who this might be right for
GERD
AstraZeneca 100
Large-scale testing (Phase 3)Study completedNCT01400945
What this trial is testing

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal Reflux Disease
Ahn-Gook Pharmaceuticals Co.,Ltd 154
Not applicableLooking for participantsNCT05976165
What this trial is testing

Breath Testing for Small Intestinal Bacterial Overgrowth

Who this might be right for
Gastroesophageal RefluxRegurgitationHeartburn
Mayo Clinic 50
Large-scale testing (Phase 3)Looking for participantsNCT01696734
What this trial is testing

Domperidone in Treating Patients With Gastrointestinal Disorders

Who this might be right for
Digestive System DisorderDyspepsiaEsophagitis+4 more
M.D. Anderson Cancer Center 200
Not applicableStudy completedNCT01797939
What this trial is testing

Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients

Who this might be right for
Erosive Reflux DiseaseNon-erosive Reflux DiseaseFunctional Heartburn
Seoul National University Bundang Hospital 197
Post-approval studies (Phase 4)Study completedNCT01397084
What this trial is testing

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Who this might be right for
Gastroesophageal Reflux DiseaseGERDReflux Esophagitis
AstraZeneca 107
Early research (Phase 1)Study completedNCT01149395
What this trial is testing

Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn

Who this might be right for
HeartburnGastroesophageal Reflux Disease
University of North Carolina, Chapel Hill 40
Post-approval studies (Phase 4)Ended earlyNCT01404832
What this trial is testing

The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors

Who this might be right for
Gastroesophageal Reflux DiseaseEosinophilic Esophagitis
Dallas VA Medical Center 102
Not applicableUnknownNCT05162079
What this trial is testing

Protocol for the ESREFLUJO Study: Epidemiological Study of Heartburn and Gastroesophageal Reflux in Community Pharmacy

Who this might be right for
Reflux
Universidad Miguel Hernandez de Elche 1,200
Not applicableStudy completedNCT01536080
What this trial is testing

Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life

Who this might be right for
Reflux Esophagitis (RE)Non-erosive Reflux Disease (NERD)Functional Heartburn (FH)
Seoul National University Bundang Hospital 207
Post-approval studies (Phase 4)Study completedNCT01587885
What this trial is testing

Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)

Who this might be right for
Heartburn
Bayer 48
Post-approval studies (Phase 4)Study completedNCT00492622
What this trial is testing

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

Who this might be right for
GastroparesisGastroesophageal Reflux Disease
University of Louisville 12
Testing effectiveness (Phase 2)UnknownNCT01129713
What this trial is testing

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Who this might be right for
Gastroesophageal Reflux Disease (GERD)HeartburnIndigestion
Effexus Pharmaceutical 40
Not applicableStudy completedNCT04119817
What this trial is testing

Effects of Mucosave® on Gastrointestinal Discomfort

Who this might be right for
Gastrointestinal Discomfort
Azienda Ospedaliera Universitaria Policlinico "G. Martino" 100
Early research (Phase 1)Study completedNCT00847210
What this trial is testing

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal Reflux
Takeda 36
Post-approval studies (Phase 4)Study completedNCT01882088
What this trial is testing

Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD

Who this might be right for
Gastroesophageal Reflux Disease
Russian Academy of Medical Sciences 36
Post-approval studies (Phase 4)UnknownNCT02140073
What this trial is testing

Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity

Who this might be right for
GERD
Belarusian Medical Academy of Post-Graduate Education 60
Testing effectiveness (Phase 2)Study completedNCT01059383
What this trial is testing

Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms

Who this might be right for
Gastroesophageal Reflux
Vecta Ltd. 52
Load More Results